Lupin LimitedNSE: LUPIN

Press Release Mar 27 2023

· Issued by Lupin Limited

Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated March 27, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Valbenazine Capsules.".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases